Ledger.Open graph →
SEC Form D · filed August 24, 2021

Linnaeus Therapeutics, Inc

Offering
$4.3M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HADDONFIELD, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Nicholas T. Iatropoulos · HADDONFIELD, NJDirectorMichael D. Poisel · HADDONFIELD, NJDirectorPatrick T. Mooney · HADDONFIELD, NJExec · DirectorTodd T. Thomson · HADDONFIELD, NJDirectorNicholas T. Iatropoulos · HADDONFIELD, NJDirectorMichael D. Poisel · HADDONFIELD, NJDirectorPatrick T. Mooney · The Woodlands, TXExec · DirectorTodd T. Thomson · HADDONFIELD, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗